1. Home
  2. DLXY vs ABP Comparison

DLXY vs ABP Comparison

Compare DLXY & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLXY
  • ABP
  • Stock Information
  • Founded
  • DLXY 2007
  • ABP 2004
  • Country
  • DLXY Singapore
  • ABP United States
  • Employees
  • DLXY N/A
  • ABP N/A
  • Industry
  • DLXY
  • ABP Biotechnology: Pharmaceutical Preparations
  • Sector
  • DLXY
  • ABP Health Care
  • Exchange
  • DLXY Nasdaq
  • ABP Nasdaq
  • Market Cap
  • DLXY 13.9M
  • ABP 15.2M
  • IPO Year
  • DLXY 2025
  • ABP N/A
  • Fundamental
  • Price
  • DLXY $1.07
  • ABP $0.18
  • Analyst Decision
  • DLXY
  • ABP Hold
  • Analyst Count
  • DLXY 0
  • ABP 1
  • Target Price
  • DLXY N/A
  • ABP N/A
  • AVG Volume (30 Days)
  • DLXY 223.3K
  • ABP 4.5M
  • Earning Date
  • DLXY 11-13-2025
  • ABP 11-18-2025
  • Dividend Yield
  • DLXY N/A
  • ABP N/A
  • EPS Growth
  • DLXY N/A
  • ABP N/A
  • EPS
  • DLXY 0.07
  • ABP N/A
  • Revenue
  • DLXY $314,916,000.00
  • ABP $183,000.00
  • Revenue This Year
  • DLXY N/A
  • ABP N/A
  • Revenue Next Year
  • DLXY N/A
  • ABP N/A
  • P/E Ratio
  • DLXY $15.61
  • ABP N/A
  • Revenue Growth
  • DLXY 8.90
  • ABP 154.17
  • 52 Week Low
  • DLXY $0.64
  • ABP $0.15
  • 52 Week High
  • DLXY $7.16
  • ABP $11.19
  • Technical
  • Relative Strength Index (RSI)
  • DLXY N/A
  • ABP 41.92
  • Support Level
  • DLXY N/A
  • ABP $0.19
  • Resistance Level
  • DLXY N/A
  • ABP $0.21
  • Average True Range (ATR)
  • DLXY 0.00
  • ABP 0.02
  • MACD
  • DLXY 0.00
  • ABP 0.00
  • Stochastic Oscillator
  • DLXY 0.00
  • ABP 17.48

About DLXY Delixy Holdings Limited Ordinary Shares

Delixy Holdings Ltd a holding company that operates through subsidiary. It is engaged in the trading of oil-related products, which can be categorized into crude oil, and oil-based products such as naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. The company has two reportable segments: the Sale of crude oil and the Sale of oil-based products. Key revenue is generated from the Sale of crude oil.

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Share on Social Networks: